Find clinical trials for Endometrial Cancer in San Diego, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near San Diego, CA, USA:
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
La Jolla, California, United States and 202 other locations
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...
Phase 2
La Jolla, California, United States of America and 16 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...
Phase 1, Phase 2
San Diego, California, United States and 31 other locations
in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...
Phase 1, Phase 2
La Jolla, California, United States and 66 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
La Jolla, California, United States of America and 230 other locations
dose (RP2D) of E7386 in combination with other anticancer drug(s), and to determine the optimal dose of E7386 in combination with lenvatinib in endometrial...
Phase 1, Phase 2
La Jolla, California, United States and 59 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
San Diego, California, United States and 93 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
La Jolla, California, United States and 123 other locations
deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors.This study will consist of Part 1 which includes 7 cohorts of: uroth ...
Phase 2
La Jolla, California, United States and 120 other locations
Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers...
Phase 1, Phase 2
La Jolla, California, United States and 75 other locations
Clinical trials
Research sites
Resources
Legal